This study will be a randomized, controlled, parallel study.~It will be conducted on 46 patients diagnosed with NASH~The patients will be randomized into two groups:~Group 1(n=23): patients will receive Rosuvastatin 20mg/day orally~Group 2(n=23): patients will receive Coenzyme Q10 100 mg/day orally~The patients will be selected from community awareness campaigns about NASH in Alexandria , Egypt . Written informed consent will be obtained from all patients. This study will be approved by the Research Ethics Committee of Tanta University and Alexandria university.~The study duration will be 3 months.
This study will be a randomized, controlled, parallel study that aims to evaluate the efficacy and safety of Rosuvastatin versus Coenzyme Q10 on nonalcoholic steatohepatitis patients.